UNSPSC 51172152: Trepibutone

This classification denotes an antispasmotic agent with the molecular formula C16H22O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier H1187LU49Q, chemically known as 2,4,5-triethoxy-gamma-oxobenzenebutanoic acid but generally known as trepibutone, which bears US NIH Compound Identifier 5536. European Medicines Agency schedules Trepibutone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11236MIG.

UNSPSC 51172152 Trepibutone is a Commodity code that, based on recent state and local solicitation activity, covers drug testing services and specimen collection operations for offender monitoring and correctional supervision programs. State and local government buyers under this code are primarily correctional and community supervision departments within county-level systems. The scope of work includes staffing specimen collection sites, operating randomized testing notification systems, performing immunoassay screening with confirmatory testing via LC/MS/MS or GC/MS, electronic result reporting, and alternative testing methodologies such as oral fluid and hair analysis. Vendors must maintain lab certification from SAMHSA, Texas DPS, or CAP. Pricing is structured on a per-test basis across three service models—screening only, confirmation after screening, and screening with automatic confirmation of positives—with all costs including freight, delivery, insurance, and staffing rolled into the per-test rate.

Collin County Community Supervision and Corrections Department, located in Texas, posted RFP 2026-327 for offender specimen collection and drug testing services with a due date of July 23, 2026. The contract encompasses staffing two collection sites in Plano and McKinney, with an estimated annual volume of approximately 25,031 tests across five-panel and six-panel screens plus ancillary testing. The contract value is $600,000, with an initial two-year term commencing September 1, 2026, and three optional one-year renewal periods for a potential five-year total. Evaluation criteria weight vendor understanding and qualifications at 30 and 25 points respectively, client references at 15 points, and cost at 30 points, with optional Phase 2 demonstrations and interviews worth up to an additional 30 points. The anticipated award date is August 10, 2026.